ArticleScientific reports2022
Multicenter clinical outcomes of hole implantable collamer lens implantation in middle-aged patients.
Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 13 citations in OpenAlex.
- Long-term evaluation of anterior segment structures after implantable collamer lens V4c implantation.International ophthalmology · 2026Article
- A comparative study on the influence of age-specific ocular anatomical differences on the prediction of post-ICL surgery vault.BMC ophthalmology · 2026Article
- Clinical characteristics and postoperative outcomes of posterior chamber intraocular lens implantation in patients aged 46 years and above.Scientific reports · 2025Article
- Visual related quality of life after ICL V4c implantation in high myopia patients: a mini review.Frontiers in medicine · 2025Review
- One-stage versus two-stage bilateral implantable collamer lens implantation: a comparison of efficacy and safety.Scientific reports · 2024Article
- Bibliometric and visualized analysis of posterior chamber phakic intraocular lens research between 2003 and 2023.Frontiers in medicine · 2024Review
- Changes of dysfunctional lens index before and after implantable collamer lens V4c implantation in patients with moderate-to-high myopia.International ophthalmology · 2023Article
- Diagnostic Techniques to Increase the Safety of Phakic Intraocular Lenses.Diagnostics (Basel, Switzerland) · 2023Review
- Intraocular Implantable Collamer Lens with a Central Hole Implantation: Safety, Efficacy, and Patient Outcomes.Clinical ophthalmology (Auckland, N.Z.) · 2023Review
- Complications following implantation of posterior chamber phakic intraocular lens (pIOL).BMJ case reports · 2022Article
- Early outcomes of anterior segment parameters after implantable collamer lens V4c implantation.BMC ophthalmology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To assess the multicenter clinical outcomes of the implantation of hole implantable collamer lens (Hole ICL, ICL KS-AquaPORTTM; STAAR Surgical, Nidau, Switzerland) in patients of 45 years or more. We retrospectively assessed the surgery's safety, efficacy, predictability, stability, and adverse events before surgery and after the surgery at 1 week; 1, 3, and 6 months; and 1 year, followed by once every year for approximately 2.2 years. A total of 118 eyes of 65 patients aged 45-65 years with myopic refractive errors ranging from - 2.13 to - 18.75 diopters (D) underwent hole ICL implantation and routine postoperative examinations. The average observation period was 2.2 ± 1.0 years. The safety and efficacy indices were 1.08 ± 0.21 and 0.87 ± 0.25, respectively. Manifest refraction changes of - 0.20 ± 0.43 D occurred from 1 month to the final visit after ICL implantation. Eight eyes (6.8%) developed asymptomatic anterior subcapsular cataract (ASC) immediately after surgery, and three eyes (2.5%) developed clinically significant symptomatic nuclear cataracts during the follow-up period. According to our experience, hole ICL implantation offered favorable outcomes in all measures of safety, efficacy, predictability, and stability, even in middle-aged patients, during the 2.2-year observation period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.